Healthcare - Biotechnology - NASDAQ - US
$ 11.19
-5.65 %
$ 472 M
Market Cap
-3.79
P/E
Price Target
Average
230.65%
Revenue Forecast
Estimate
62.72%
EBIT
Estimate
--70.65%
Net Income
Estimate
32.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
UroGen Pharma Ltd.
Wall Street analysts predict an average 1-year price target for URGN of $37 , with forecasts ranging from a low of $22 to a high of $60 .
URGN Lowest Price Target
Wall Street Target
22 USD
96.60%
URGN Average Price Target
Wall Street Target
37 USD
230.65%
URGN Highest Price Target
Wall Street Target
60 USD
436.19%
REVENUE FORECAST
Revenue Forecast Chart URGN
EBIT FORECAST
EBIT Forecast Chart URGN
NET INCOME FORECAST
Net Income Chart URGN